Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin W Fischer-Valuck

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
The Journal of Urology|August 27, 2017
Treatment Patterns and Overall Survival Outcomes of Octogenarians with Muscle Invasive Cancer of the Bladder: An Analysis of the National Cancer DatabaseBenjamin W Fischer-Valuck, Yuan James Rao, Soumon Rudra, et al.
European Urology Focus|September 19, 2017
Treatment Patterns and Survival Outcomes for Patients with Small Cell Carcinoma of the BladderBenjamin W Fischer-Valuck, Yuan James Rao, Lauren E Henke, et al.
International Journal of Radiation Oncology, Biology, Physics|October 14, 2015
Brachytherapy Is Associated With Improved Survival in Inoperable Stage I Endometrial Adenocarcinoma: A Population-Based AnalysisSahaja Acharya, Stephanie M Perkins, Todd DeWees, et al.
Clinical Genitourinary Cancer|January 28, 2022
Propensity-Weighted Survival Analysis of SBRT vs. Conventional Radiotherapy in Unfavorable Intermediate-Risk Prostate CancerNeal Andruska, Benjamin W Fischer-Valuck, Temitope Agabalogun, et al.
Brachytherapy|May 31, 2022
Assessing the impact of brachytherapy boost and androgen deprivation therapy on survival outcomes for patients with unfavorable intermediate-risk prostate cancer patients treated with external beam radiotherapyNeal Andruska, Temitope Agabalogun, Benjamin W Fischer-Valuck, et al.
Cancer|November 19, 2016
Assessment of the treatment approach and survival outcomes in a modern cohort of patients with atypical teratoid rhabdoid tumors using the National Cancer DatabaseBenjamin W Fischer-Valuck, Ishita Chen, Amar J Srivastava, et al.
Practical Radiation Oncology|May 12, 2023
Benchmarking the Radiation Oncology Alternative Payment Model: Changes in Medicare Reimbursement for 16 Common Radiation Therapy Treatment CoursesJacob S Hogan, Patricia Karraker, Benjamin W Fischer-Valuck, et al.
JAMA Dermatology|March 24, 2021
Association Between Surgical Margins Larger Than 1 cm and Overall Survival in Patients With Merkel Cell CarcinomaNeal Andruska, Benjamin W Fischer-Valuck, Lily Mahapatra, et al.
Practical Radiation Oncology|June 11, 2025
Analysis of Medicare Reimbursement Trends in Medical and Radiation OncologyJacob S Hogan, John C Baumann, Neha Vapiwala, et al.
Brachytherapy|January 12, 2023
Association of Brachytherapy Boost with Overall Survival for Gleason 9-10 Prostate Cancer: The Impact of Primary versus Secondary Pattern 5Sagar A Patel, Brian Baumann, Jeff Michalski, et al.
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
The Journal of Urology|August 27, 2017
Treatment Patterns and Overall Survival Outcomes of Octogenarians with Muscle Invasive Cancer of the Bladder: An Analysis of the National Cancer DatabaseBenjamin W Fischer-Valuck, Yuan James Rao, Soumon Rudra, et al.
European Urology Focus|September 19, 2017
Treatment Patterns and Survival Outcomes for Patients with Small Cell Carcinoma of the BladderBenjamin W Fischer-Valuck, Yuan James Rao, Lauren E Henke, et al.
International Journal of Radiation Oncology, Biology, Physics|October 14, 2015
Brachytherapy Is Associated With Improved Survival in Inoperable Stage I Endometrial Adenocarcinoma: A Population-Based AnalysisSahaja Acharya, Stephanie M Perkins, Todd DeWees, et al.
Clinical Genitourinary Cancer|January 28, 2022
Propensity-Weighted Survival Analysis of SBRT vs. Conventional Radiotherapy in Unfavorable Intermediate-Risk Prostate CancerNeal Andruska, Benjamin W Fischer-Valuck, Temitope Agabalogun, et al.
Brachytherapy|May 31, 2022
Assessing the impact of brachytherapy boost and androgen deprivation therapy on survival outcomes for patients with unfavorable intermediate-risk prostate cancer patients treated with external beam radiotherapyNeal Andruska, Temitope Agabalogun, Benjamin W Fischer-Valuck, et al.
Cancer|November 19, 2016
Assessment of the treatment approach and survival outcomes in a modern cohort of patients with atypical teratoid rhabdoid tumors using the National Cancer DatabaseBenjamin W Fischer-Valuck, Ishita Chen, Amar J Srivastava, et al.
Practical Radiation Oncology|May 12, 2023
Benchmarking the Radiation Oncology Alternative Payment Model: Changes in Medicare Reimbursement for 16 Common Radiation Therapy Treatment CoursesJacob S Hogan, Patricia Karraker, Benjamin W Fischer-Valuck, et al.
JAMA Dermatology|March 24, 2021
Association Between Surgical Margins Larger Than 1 cm and Overall Survival in Patients With Merkel Cell CarcinomaNeal Andruska, Benjamin W Fischer-Valuck, Lily Mahapatra, et al.
Practical Radiation Oncology|June 11, 2025
Analysis of Medicare Reimbursement Trends in Medical and Radiation OncologyJacob S Hogan, John C Baumann, Neha Vapiwala, et al.
Brachytherapy|January 12, 2023
Association of Brachytherapy Boost with Overall Survival for Gleason 9-10 Prostate Cancer: The Impact of Primary versus Secondary Pattern 5Sagar A Patel, Brian Baumann, Jeff Michalski, et al.
Pageof 6